AT347607B - Verfahren zur herstellung eines neuen prostaglandins - Google Patents

Verfahren zur herstellung eines neuen prostaglandins

Info

Publication number
AT347607B
AT347607B AT937173A AT937173A AT347607B AT 347607 B AT347607 B AT 347607B AT 937173 A AT937173 A AT 937173A AT 937173 A AT937173 A AT 937173A AT 347607 B AT347607 B AT 347607B
Authority
AT
Austria
Prior art keywords
prostaglandine
producing
new
new prostaglandine
Prior art date
Application number
AT937173A
Other languages
German (de)
English (en)
Other versions
ATA937173A (de
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ATA937173A publication Critical patent/ATA937173A/de
Application granted granted Critical
Publication of AT347607B publication Critical patent/AT347607B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/54—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5407—Acyclic saturated phosphonium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
AT937173A 1972-11-08 1973-11-07 Verfahren zur herstellung eines neuen prostaglandins AT347607B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30481572A 1972-11-08 1972-11-08

Publications (2)

Publication Number Publication Date
ATA937173A ATA937173A (de) 1978-05-15
AT347607B true AT347607B (de) 1979-01-10

Family

ID=23178143

Family Applications (1)

Application Number Title Priority Date Filing Date
AT937173A AT347607B (de) 1972-11-08 1973-11-07 Verfahren zur herstellung eines neuen prostaglandins

Country Status (24)

Country Link
JP (1) JPS5644068B2 (fr)
AR (2) AR204816A1 (fr)
AT (1) AT347607B (fr)
BE (1) BE807047A (fr)
CA (1) CA1027559A (fr)
CH (1) CH601222A5 (fr)
CS (1) CS188175B2 (fr)
DD (2) DD113211A5 (fr)
DE (2) DE2355042A1 (fr)
ES (2) ES420326A1 (fr)
FI (1) FI58116C (fr)
FR (2) FR2205339B1 (fr)
GB (1) GB1456511A (fr)
HU (2) HU171945B (fr)
IE (1) IE39686B1 (fr)
IL (1) IL43553A (fr)
IN (1) IN139905B (fr)
NL (1) NL7315240A (fr)
NO (2) NO145437C (fr)
PH (2) PH15504A (fr)
SE (2) SE420198B (fr)
SU (2) SU538659A3 (fr)
YU (2) YU287973A (fr)
ZA (1) ZA738593B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2361381A1 (fr) * 1972-07-13 1978-03-10 Pfizer Ethers tetrahydropyranyliques, utiles comme intermediaires de synthese de prostaglandines
US3929862A (en) * 1974-01-08 1975-12-30 Upjohn Co Substituted tolylesters of PGF{HD 2{B {60
US3998869A (en) * 1974-11-14 1976-12-21 The Upjohn Company Substituted anilide esters of 16-substituted PGE2
DE2737807A1 (de) * 1976-08-27 1978-03-09 Pfizer C tief 1 -p-biphenylester von omega-pentanorprostaglandinen
US6531504B2 (en) * 2001-05-17 2003-03-11 Allergan, Inc. Prostanoic acid derivatives as agents for lowering intraocular pressure

Also Published As

Publication number Publication date
DE2365999A1 (de) 1977-05-12
IL43553A (en) 1979-10-31
AR204816A1 (es) 1976-03-05
NL7315240A (fr) 1974-05-10
ATA937173A (de) 1978-05-15
IN139905B (fr) 1976-08-14
JPS49100060A (fr) 1974-09-20
PH13794A (en) 1980-10-01
NO145437B (no) 1981-12-14
HU171945B (hu) 1978-04-28
CS188175B2 (en) 1979-02-28
SU1021340A3 (ru) 1983-05-30
IL43553A0 (en) 1974-03-14
YU287973A (en) 1982-02-25
AU6222573A (en) 1975-05-08
FR2275452B1 (fr) 1977-12-16
NO743588L (no) 1974-05-09
FR2205339B1 (fr) 1980-01-04
CA1027559A (fr) 1978-03-07
IE39686L (en) 1974-05-08
PH15504A (en) 1983-02-03
ES420326A1 (es) 1976-03-16
NO146280B (no) 1982-05-24
JPS5644068B2 (fr) 1981-10-16
BE807047A (fr) 1974-05-08
FR2205339A1 (fr) 1974-05-31
NO145437C (no) 1982-03-24
FR2275452A1 (fr) 1976-01-16
HU171818B (hu) 1978-03-28
IE39686B1 (en) 1978-12-06
DD113211A5 (fr) 1975-05-20
FI58116B (fi) 1980-08-29
GB1456511A (en) 1976-11-24
FI58116C (fi) 1980-12-10
SU538659A3 (ru) 1976-12-05
SE420198B (sv) 1981-09-21
NO146280C (no) 1982-09-01
DD111370A5 (fr) 1975-02-12
YU264480A (en) 1983-04-27
ES434687A1 (es) 1976-12-16
DE2355042A1 (de) 1974-05-22
CH601222A5 (fr) 1978-06-30
AR202311A1 (es) 1975-05-30
ZA738593B (en) 1974-10-30
SE7704369L (sv) 1977-04-15

Similar Documents

Publication Publication Date Title
AT332883B (de) Verfahren zur herstellung von neuen alkyl-benzimidazolylcarbamaten
DD132786A5 (de) Verfahren zur herstellung eines neuen oximaethers
AT329589B (de) Verfahren zur herstellung eines neuen nichtionischen zelluloseathers
AT340686B (de) Verfahren zur herstellung eines polyelektrolyten
AT356810B (de) Verfahren zur herstellung von neuen substituierten cephalosporinen
AT329203B (de) Verfahren zur herstellung von neuen heptapeptiden
AT345999B (de) Verfahren zur herstellung von neuen 15- substituierten omega-pentanorprostaglandinen
ATA583473A (de) Verfahren zur herstellung von neuen sufonamidodiphenylathern
AT348138B (de) Verfahren zur herstellung eines neuen komplexes
AT332357B (de) Verfahren zur herstellung eines nickel-auf-aluminium-katalysators
AT330349B (de) Verfahren zur herstellung eines ubertragungsfaktors
AT347607B (de) Verfahren zur herstellung eines neuen prostaglandins
AT348141B (de) Verfahren zur herstellung eines neuen 6-methyl- 8- (substituierten) methylergolins
AT351185B (de) Verfahren zur herstellung eines neuen 11- desoxy-omega-pentanorprostaglandins
AT324563B (de) Verfahren zur herstellung eines neuen antibiotikums
AT348520B (de) Verfahren zur herstellung eines neuen tetrazolderivats
ATA293273A (de) Verfahren zur herstellung eines neuen metaboliten
AT323910B (de) Verfahren zur herstellung eines neuen triamcinolonderivates
AT327383B (de) Verfahren zur herstellung eines neuen antibiotikums
AT356055B (de) Verfahren zur herstellung eines schussfaden- losen bandes
AT342008B (de) Verfahren zur herstellung eines katalysators
CH556859A (de) Verfahren zur herstellung eines triazolyl-naphthalimids.
AT339474B (de) Verfahren zur herstellung eines neuen metaboliten
ATA987676A (de) Verfahren zur herstellung eines neuen cyclopentanderivats
ATA856874A (de) Verfahren zur herstellung eines neuen zwischenproduktes

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee